What You Should Know:
– Waltz Health, a digital health company specializing in medication pricing and distribution, and Noom, a leader in digital health and chronic disease prevention, have announced a unique partnership to provide employers and health plans with a comprehensive and affordable weight loss program.
– The collaboration will leverage Waltz Connect, Waltz Health’s innovative platform, to streamline access to GLP-1 medications, making them more accessible and cost-effective for employees.
Addressing the Rising Cost of Obesity
Obesity is a significant health concern with substantial economic implications. Studies estimate that overweight and obese workers cost U.S. businesses and employees a staggering $425.5 billion annually. While GLP-1 drugs have proven effective in treating obesity and related cardiovascular issues, their high cost often makes them inaccessible for many individuals and employers.
Streamlining Access to GLP-1 Medications
By integrating Waltz Connect into Noom Med, employees who qualify for a GLP-1 prescription will have seamless access to their medication at a significantly lower cost. This integration will:
- Reduce Costs: Bypass traditional intermediaries and leverage Waltz Connect’s dynamic marketplace to secure the most affordable prices for GLP-1 medications.
- Enhance Transparency: Provide employees with upfront visibility into medication costs through the Noom app.
- Improve Patient Experience: Streamline the prescription fulfillment process and improve medication adherence.
Waltz Connect: Transforming Specialty Medication Management
Launched in August, Waltz Connect offers unmatched transparency and cost-effectiveness in specialty medication management. Its flexible design allows it to be deployed across entire formularies, specific drug classes, or even individual drugs.
“GLP-1 drugs have been a game-changer in the health and wellness space, but supply chain challenges and affordability issues have created broken experiences for many while wholly eliminating access for others. However, we know that there are opportunities to eliminate friction and find savings within the system by intelligently routing prescriptions using AI to uncover the best pharmacy option,” said Waltz Health Co-founder and CEO Mark Thierer. “People shouldn’t have to spend their time searching for pharmacies that have medications in stock or who have the best price. By combining Noom’s personalized, behavior science-driven program with our Waltz Connect platform, we’re ensuring employees both have access to more affordable medications and understand when and how to expect their prescriptions.”
